{"created":"2023-07-25T10:25:30.109861+00:00","id":5873,"links":{},"metadata":{"_buckets":{"deposit":"458b42b9-6acb-4b3c-b56f-04405754be56"},"_deposit":{"created_by":15,"id":"5873","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"5873"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:00005873","sets":["611:939:940"]},"author_link":["16787","16788"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"267","bibliographicPageStart":"258","bibliographicVolumeNumber":"16","bibliographic_titles":[{"bibliographic_title":"Reproductive Medicine and Biology","bibliographic_titleLang":"en"}]}]},"item_10001_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"Aim\nIn recent years, the importance of fertility preservation (FP) has increased. In vitro maturation (IVM), an important technique in FP, has started to be used in the clinic, but controversies persist regarding this technique. Here, a survey of IVM for FP is provided.\nMethods\nBased on a literature review, the applications of FP, methods of FP, IVM of oocytes that had been collected in vivo and ex vivo, maturation of oocytes after IVM for FP, cryopreservation of oocytes for FP, explanation of the procedures to patients, and recent research on FP using IVM were investigated.\nResults\nAlthough IVM for FP remains controversial, the application of FP is expected to expand. Depending on the age and disease status of the patient, various methods of oocyte collection and ovarian stimulation, as well as various needle types and aspiration pressures, have been reported. The maturation rate of IVM in FP ranges widely and requires optimization in the future. In regard to cryopreservation for matured oocytes, the vitrification method is currently recommended.\nConclusion\nRegarding FP for patients with cancer, the treatment of cancer is prioritized; thus, the time and use of medicines are often constrained. As several key points regarding IVM remain unclear, well-designed and specific counseling for patients is necessary.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"John Wiley and Sons Inc"}]},"item_10001_relation_25":{"attribute_name":"関連情報","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1002/rmb2.12042","subitem_relation_type_select":"DOI"}}]},"item_10001_rights_15":{"attribute_name":"権利情報","attribute_value_mlt":[{"subitem_rights":"This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. © 2017 The Authors. Reproductive Medicine and Biology published by John Wiley & Sons Australia, Ltd on behalf of Japan Society for Reproductive Medicine."}]},"item_10001_version_type_20":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1724099666130":{"attribute_name":"収録物識別子","attribute_value_mlt":[{"subitem_source_identifier":"1447-0578","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"作成者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Shirasawa, Hiromitsu","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"16787","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Terada, Yukihiro","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"16788","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-02-19"}],"displaytype":"detail","filename":"iA_2022_50.pdf","filesize":[{"value":"440.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"iA_2022_50.pdf","url":"https://air.repo.nii.ac.jp/record/5873/files/iA_2022_50.pdf"},"version_id":"c19aa378-2148-486d-a2e2-a1bc4fed49fb"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"assisted reproductive technology","subitem_subject_scheme":"Other"},{"subitem_subject":"cryopreservation","subitem_subject_scheme":"Other"},{"subitem_subject":"fertility preservation","subitem_subject_scheme":"Other"},{"subitem_subject":"in vitro maturation","subitem_subject_scheme":"Other"},{"subitem_subject":"oncofertility","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"In vitro maturation of human immature oocytes for fertility preservation and research material","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"In vitro maturation of human immature oocytes for fertility preservation and research material","subitem_title_language":"en"}]},"item_type_id":"10001","owner":"15","path":["940"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-02-19"},"publish_date":"2023-02-19","publish_status":"0","recid":"5873","relation_version_is_last":true,"title":["In vitro maturation of human immature oocytes for fertility preservation and research material"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2024-08-24T14:04:31.835059+00:00"}